Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5451]

Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Challenges and importance of long-term treatment for newly diagnosed multiple...

Prof Sagar Lonial, Prof Meral Beksaç, Dr Robert Rifkin

Challenges and importance of long-term treatment for newly diagnosed multiple myeloma patients; community-based trial data ( Prof Sagar Lonial, Prof Meral Beksaç, Dr Robert Rifkin )

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise

Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )

Evaluating emerging mutations in patients with acute myeloid leukaemia who...

Dr Catherine Smith - University of California San Francisco, San Francisco, USA

Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial ( Dr Catherine Smith - University of California San Francisco, San Francisco, USA )

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD...

Dr James Foran - Mayo Clinic Florida, Jacksonville, USA

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients ( Dr James Foran - Mayo Clinic Florida, Jacksonville, USA )

Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma

Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China

Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )

Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin...

Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA

Mosunetuzumab induces complete remissions in poor prognosis non-Hodgkin lymphoma patients ( Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA )

CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained...

Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China

CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )

Dual-targeted antibody mosunetuzumab elicits durable responses in poor...

Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA

Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients ( Prof Stephen Schuster - University of Pennsylvania, Philadelphia, USA )

Providing practical tips for completing geriatric assessments

Dr Melissa Loh - Rochester Medical Center, Rochester, USA

Providing practical tips for completing geriatric assessments ( Dr Melissa Loh - Rochester Medical Center, Rochester, USA )

A dedicated, multidisciplinary support team for palliative care patients

Dr Ishwaria Subbiah - MD Anderson Cancer Center, Houston, USA

A dedicated, multidisciplinary support team for palliative care patients ( Dr Ishwaria Subbiah - MD Anderson Cancer Center, Houston, USA )

Polypharmacy and medication management in geriatric oncology

Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA

Polypharmacy and medication management in geriatric oncology ( Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA )

More from ecancer